BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 37122536)

  • 1. The Diagnostic Power of Circulating miR-1246 in Screening Cancer: An Updated Meta-analysis.
    Huynh KQ; Le AT; Phan TT; Ho TT; Pho SP; Nguyen HT; Le BT; Nguyen TT; Nguyen ST
    Oxid Med Cell Longev; 2023; 2023():8379231. PubMed ID: 37122536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA panels as diagnostic biomarkers for colorectal cancer: A systematic review and meta-analysis.
    Sur D; Advani S; Braithwaite D
    Front Med (Lausanne); 2022; 9():915226. PubMed ID: 36419785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-223 in gastrointestinal cancers: A systematic review and diagnostic meta-analysis.
    Aalami AH; Abdeahad H; Mesgari M; Sahebkar A
    Eur J Clin Invest; 2021 Feb; 51(2):e13448. PubMed ID: 33244751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Accuracy of Single MicroRNAs in Peripheral Blood to Diagnose Ovarian Cancer: An Updated Meta-Analysis.
    Cui Y; Hong S; Zhu X
    Dis Markers; 2020; 2020():1075942. PubMed ID: 32025275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Role of MicroRNA-375 as Biomarker in Human Cancers Detection: A Meta-Analysis.
    Yan J; She Q; Shen X; Zhang Y; Liu B; Zhang G
    Biomed Res Int; 2017; 2017():1875843. PubMed ID: 29259977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential diagnostic accuracy of circulating microRNAs for prostate cancer: A meta-analysis.
    Zhang WT; Zhang GX; Zhao RZ; Gao SS
    Actas Urol Esp (Engl Ed); 2022 Apr; 46(3):138-149. PubMed ID: 35260368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of circulating microRNAs for esophageal cancer: a meta-analysis based on Asian data.
    Zhang WT; Wang YJ; Zhang GX; Zhang YH; Gao SS
    Rev Esp Enferm Dig; 2023 Sep; 115(9):504-514. PubMed ID: 35040334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain tumors and circulating micrornas: a systematic review and diagnostic meta-analysis.
    Aalami AH; Abdeahad H; Shoghi A; Mesgari M; Amirabadi A; Sahebkar A
    Expert Rev Mol Diagn; 2022 Feb; 22(2):201-211. PubMed ID: 34906021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of microRNA-21 expression as a potential screening biomarker for colorectal cancer: a meta-analysis.
    Jiang JX; Zhang N; Liu ZM; Wang YY
    Asian Pac J Cancer Prev; 2014; 15(18):7583-8. PubMed ID: 25292032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of circulating cell-free DNA analysis as a diagnostic tool for breast cancer: a meta-analysis.
    Lin Z; Neiswender J; Fang B; Ma X; Zhang J; Hu X
    Oncotarget; 2017 Apr; 8(16):26625-26636. PubMed ID: 28460452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection Performance of Circulating MicroRNA-210 for Renal Cell Carcinoma: a Meta-Analysis.
    Chen Y; Wang X; Zhu X; Shao S
    Clin Lab; 2018 Apr; 64(4):569-576. PubMed ID: 29739083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating microRNAs as Potential Biomarkers for the Diagnosis of Endometrial Cancer: a Meta-Analysis.
    Gao J; Fan YZ; Gao SS; Zhang WT
    Reprod Sci; 2023 Feb; 30(2):464-472. PubMed ID: 35764858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-21 as a potential biomarker for detecting esophageal carcinoma in Asian populations: a meta-analysis.
    Han Z; Pan L; Lu B; Zhu H
    PeerJ; 2022; 10():e14048. PubMed ID: 36199284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric Cancer and Circulating microRNAs: An Updated Systematic Review and Diagnostic Meta-Analysis.
    Aalami AH; Aalami F; Sahebkar A
    Curr Med Chem; 2023; 30(33):3798-3814. PubMed ID: 36411580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating miR-21 as a potential biomarker in human digestive system carcinoma: a systematic review and diagnostic meta-analysis.
    Aalami AH; Abdeahad H; Mesgari M
    Biomarkers; 2021 Mar; 26(2):103-113. PubMed ID: 33434077
    [No Abstract]   [Full Text] [Related]  

  • 16. The diagnostic role of microRNA-34a in breast cancer: a systematic review and meta-analysis.
    Imani S; Zhang X; Hosseinifard H; Fu S; Fu J
    Oncotarget; 2017 Apr; 8(14):23177-23187. PubMed ID: 28423566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical role of miR-421 as a novel biomarker in diagnosis of gastric cancer patients: A meta-analysis.
    Xu Y; Wang G; Hu W; He S; Li D; Chen P; Zhang J; Gao Y; Yu D; Zong L
    Medicine (Baltimore); 2022 May; 101(19):e29242. PubMed ID: 35583533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of circulating microRNA in hepatitis B virus-related hepatocellular carcinoma: a meta-analysis based on Asian data.
    Zhang WT; Gil-Gómez A; Liu CH; Gao SS; Romero-Gómez M
    Rev Esp Enferm Dig; 2022 May; 114(5):280-288. PubMed ID: 34423645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Circulating MicroRNA-375 for the Detection of Liver Cancer: A Meta-Analysis.
    Kong X; He Z; Ji Z; Fu T; Yuan X; Zhou H; Shao Z; Zhang W
    Genet Test Mol Biomarkers; 2022 Dec; 26(12):564-572. PubMed ID: 36577123
    [No Abstract]   [Full Text] [Related]  

  • 20. MicroRNA-21 was a promising biomarker for lung carcinoma diagnosis: An update meta-analysis.
    Wang H; Xu J; Ding L
    Thorac Cancer; 2022 Feb; 13(3):316-321. PubMed ID: 34837469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.